Direkt zum Inhalt

Owner only: item control page
Harter, P. ; Mahner, S. ; Hilpert, F. ; Runnebaum, I. ; Ortmann, O. ; Mustea, A. ; Sehouli, J. ; du Bois, A. ; Wagner, U.

Statement by the Kommission OVAR of the AGO Study Group on the Use of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) to Treat Primary and Recurrent Ovarian Cancer

Harter, P., Mahner, S., Hilpert, F., Runnebaum, I., Ortmann, O., Mustea, A., Sehouli, J., du Bois, A. and Wagner, U. (2013) Statement by the Kommission OVAR of the AGO Study Group on the Use of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) to Treat Primary and Recurrent Ovarian Cancer. Geburtshilfe und Frauenheilkunde 73 (03), pp. 221-223.

Date of publication of this fulltext: 19 Dec 2024 08:41
Article



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleGeburtshilfe und Frauenheilkunde
Publisher:GEORG THIEME VERLAG KG
Place of Publication:STUTTGART
Volume:73
Number of Issue or Book Chapter:03
Page Range:pp. 221-223
Date2013
InstitutionsMedicine > Lehrstuhl für Frauenheilkunde und Geburtshilfe (Schwerpunkt Frauenheilkunde)
Identification Number
ValueType
10.1055/s-0032-1328320DOI
KeywordsPERITONEAL CARCINOMATOSIS; CYTOREDUCTIVE SURGERY; SYSTEMIC CHEMOTHERAPY; EXPLORATORY ANALYSIS; RANDOMIZED-TRIAL; CISPLATIN; PLATINUM; DNA; MANAGEMENT; ovarian cancer; statement; HIPEC; AGO
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgYes
Item ID62743

Export bibliographical data

Owner only: item control page

nach oben